For the most recent 12 months ending October 2014, the VALCYTE
(Valganciclovir) tablets brand had US sales of about USD440m MAT, according to IMS Health.
is a registered trademark of Genentech, Inc., a part of Roche's pharmaceutical operations in the US.
is an antiviral medication that can be effective for the prevention of cytomegalovirus (CMV) disease in children from 4 months to 16 years of age who have undergone a kidney or heart transplant and who are at a higher risk of getting the disease.
San Francisco CA), a member of the Roche Group, won approval for a longer length of therapy for Valcyte
in adult kidney transplant patients at high risk for cytomegalovirus disease.
Genentech, Inc., South San Francisco, CA, announced the FDA has approved increasing the length of therapy with Valcyte
in adult kidney transplant patients with high risk for cytomegalovirus (CMV) disease.
CMV TREATMENT IN ADULTS Drug Dose Valganciclovir Initiation 900 mg bd po (Valcyte
; phase with meals x 21 Roche) 450 mg days per tablet, 60 tablets per bottle No generics Maintenance 900 mg/d po currently phase with meals available in until HAART South Africa restores CD4 count >100 cells/[micro]l Ganciclovir Induction 5 mg/kg IV bd x (Cymevene; phase: 21 days Roche) intravenous Inj.: 500 mg in Maintenance 1 g tds po 10 ml vials x5 phase: oral Caps: 250 mg (84), 500 mg Local treatment In a recumbent (90) for CMV patient, 2 mg retinitis of a 25 mg/ml No generics ganciclovir currently solution in available in normal saline South Africa is injected with a 1 ml syringe and 30G needle, 4 mm behind the limbus of the eye superiorly with the patient looking down.
Roche's Rupp says that "Currently, MSF is the only organization requesting purchase of Valcyte
[Roche's brand name for valganciclovir] for such use in these countries.
His physician prescribed Valcyte
for CMV, Kaletra for his HIV, and Neupogen to boost his white blood cell count.
Examples of these drugs include Zovirax (acyclovir) or its generic version acyclovir, Valtrex (valacyclovir), Cytovene (ganciclovir), Valcyte
(valgancyclovir), and Vistide (cidofovir).
The drug is the generic version of Valcyte
(Hoffmann La Roche) and is used to treat cytomegalovirus infection of the eye in patients with acquired immunodeficiency syndrome.
M2 EQUITYBITES-November 11, 2014-Endo wins final US FDA's approval for generic Valcyte